secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001558370-23-017788
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix Q3 revenue $31.3M (+18% YoY), net loss narrows; raises full-year guidance
--------------------------------------------------------------------------------

- Q3 revenue $31.3M (+18% YoY); GAAP net loss narrowed to $7.8M from $35.1M.
- GAAP gross margin improved to 56.8% (41.1% prior year); non-GAAP gross margin 48.6% (34.9%).
- FY 2023 revenue guidance raised to $118-120M from $110-116M; cash usage outlook lowered to $20-25M.
- Launched LucentAD p-Tau 217 blood-based Alzheimer's test; Simoa platform used in Eli Lilly's p-Tau 217 validation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000155837023017788/0001558370-23-017788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000155837023017788/tmb-20231106x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-017788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer